High Cost, Lifelong Treatments and the Impact on Payers and Patients
Healthcare payers may not be familiar with the high costs of paroxysmal nocturnal hemoglobinuria (PNH), or even know what it is, that is until the ultra-expensive drugs prescribed to treat this condition start showing up on claim reports. With a yearly cost of treatment reaching nearly $1MM, payers and patients alike need to be considered […]
High Cost, Lifelong Treatments and the Impact on Payers and Patients Read More »
